scorecardresearch
Thursday, August 14, 2025
TopicBharat Biotech

Topic: Bharat Biotech

Bharat Biotech signs pact with Precisa Medicamentos for Covaxin supplies to Brazil

A team from Precisa Medicamentos visited the Bharat Biotech facility last week to discuss potential export possibilities of the vaccine, the company said in a release.

Death of Covaxin phase 3 volunteer not related to vaccine trial, says Bharat Biotech

Bharat Biotech says it has followed necessary protocol and preliminary review shows death unrelated to study. Volunteer sample being tested to determine cause of death. 

How India’s regulatory pitfalls helped Covishield and Covaxin get rapid approval

The lack of regulatory clarity coupled with lack of transparency from CDSCO raises questions on the safety and efficacy of the Covid-19 vaccine candidates.

Lack of data, doubts over trials and vaccine quality – India’s dangerous recovery cocktail

As India gears up to roll out a national vaccination programme, Bharat Biotech and Serum Institute's barbs at each other will only add to vaccine hesitancy.

India to follow ‘HCQ model’, will send Covid vaccines to neighbours after local demand is met

Officials say India 'will not be in a rush', and Bangladesh, Bhutan, Nepal, Sri Lanka will get ‘priority’ after domestic demand for the Covid vaccines is fulfilled.

This is how Bharat Biotech changed expert panel’s mind on Covaxin in a day and got approval

Minutes of the meetings held by the expert panel tell us what convinced it to change its mind about Covaxin despite incomplete phase 3 trial data.

After public spat, Bharat Biotech & SII jointly pledge smooth roll out of Covid vaccines

The joint statement comes after Bharat Biotech MD Dr Krishna Ella hit out at Serum CEO Adar Poonawalla’s comment that only Pfizer, Moderna, Oxford vaccines were effective.

Serum Institute, Bharat Biotech, Cadila vaccines — sifting science from non-science

In episode 653 of ‘Cut The Clutter’, the first in the new year, ThePrint’s Editor-in-Chief Shekhar Gupta explained working of Covaxin, Covishield & Zydus Cadila’s DNA vaccine.

DCGI’s Covaxin ‘approval’ is political jumla. It reinforces idea of Modi’s Atmanirbhar Bharat

The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.

Oxford trial ‘lousy’, we’ll be ready with 70 cr Covaxin doses this year, says Bharat Biotech

Bharat Biotech MD Dr Krishna Ella says they gave ‘excellent safety data tested on around 25,000 participants’ & their efficacy data will be available by February-March.

On Camera

Asim Munir wants to be guardian of the Middle East. He’s fated to fail at home

Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.

Slashing GST on waste can unlock Rs 1.8 lakh crore, high tax hurting circular economy goals—CSE

Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.

India, US troops to undertake joint military exercise next month, first after Op Sindoor

21st edition of annual joint military exercise will be held from 1 to 16 September, aimed at sharing military tech, operational best practices & disaster relief coordination methods.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.